Isomorphic Labs
William McCorkindale is a Senior Scientist at CHARM Therapeutics, contributing to drug discovery research since June 2023. Currently pursuing a PhD at the University of Cambridge, with a focus on enhancing drug discovery processes through machine learning, William's thesis explores ML applications in synthesis planning and virtual screening. Previous experience includes a Research Scientist Internship at DeepMind, working on AlphaFold, and a series of research roles at prestigious institutions such as Caltech and the Max Planck Institute, where William investigated molecular properties and particle dynamics. William holds an MSci in Physics from St. John's College, Cambridge, and a degree in Natural Sciences from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.